The thrombin receptor in the nervous system

Seminars in Thrombosis and Hemostasis

Volumn 22, Issue 2, 1996, Pages 125-133

  Suidan, Hana S ^a   Niclou, Simone P ^a   Monard, Denis ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

Astrocytes; cAMP; Lysophosphatidic acid; Neurite retraction; Platelets

Indexed keywords

THROMBIN; THROMBIN RECEPTOR;

ANIMAL CELL; ASTROCYTE; CONFERENCE PAPER; HEMOSTASIS; MOUSE; NEURITE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION; THROMBOGENESIS; THROMBOSIS;

EID: 0029894137     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-998999     Document Type: Conference Paper

References (63)

1. Krystosek A, NW Seeds: Plasminogen activator release at the neuronal growth cone. Science 213:1532-1534, 1981.
2. Krystosek A, NW Seeds: Plasminogen activator secretion by granule neurons in cultures of developing cerebellum. Proc Natl Acad Sci USA 78:7810-7814, 1981.
3. Patterson PH: On the role of proteases, their inhibitors and the extracellular matrix in promoting neurite outgrowth. J Physiol 80: 207-211, 1985.
4. Monard D: Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth. Trends Neurosci 11:541-544, 1988.
5. Pittman RN, JK Ivins, HM Buettner: Neuronal plasminogen activators: Cell surface binding sites and involvement in neurite out-growth. J Neurosci 9:4269-4286, 1989.
6. Gloor S, K Odink, J Guenther, H Nick, D Monard: A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins. Cell 47:687-693, 1986.
7. Monard D, F Solomon, M. Rentsch, R Gysin: Glia-induced morphological differentiation in neuroblastoma cells. Proc Natl Acad Sci USA 70:1894-1897, 1973.
8. Zurn AD, H Nick, D Monard: A glia-derived nexin promotes neurite outgrowth in cultured chick sympathetic neurons. Dev Neurosci 10:17-24, 1988.
9. Farmer L, J Sommer, D Monard: Glia-derived nexin potentiates neurite extension in hippocampal pyramidal cells in vitro. Dev Neurosci 12:73-80, 1990.
10. Monard D, E Niday, A Limat, F Solomon: Inhibition of protease activity can lead to neurite extension in neuroblastoma cells. Prog Brain Res 58:359-364, 1983.
11. Gurwitz D, DD Cunningham: Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc Natl Acad Sci USA 85: 3440-3444, 1988.
12. Gurwitz D, DD Cunningham: Neurite outgrowth activity of protease nexin-1 on neuroblastoma cells requires thrombin inhibition. J Cell Physiol 142:155-162, 1990.
13. Cavanaugh KP, D Gurwitz, DD Cunningham, RA Bradshaw: Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J Neurochem 54:1735-1743, 1990.
14. Nelson RB, R Siman: Thrombin and its inhibitors regulate morphological and biochemical differentiation of astrocytes in vitro. Brain Res Dev Brain Res 54:93-104, 1990.
15. Tas PW, K Koschel: Thrombin reverts the β-adrenergic agonist-induced morphological response in rat glioma C6 cells. Exp Cell Res 189:22-27, 1990.
16. Mazzoni IE, RL Kenigsberg: Thrombin indirectly affects cholinergic cell expression in primary septal cell cultures in a manner distinct from nerve growth factor. Neuroscience 45:195-204, 1991.
17. Hawkins RL, NW Seeds: Effect of proteases and their inhibitors on neurite outgrowth from neonatal mouse sensory ganglia in culture. Brain Res 398:63-70, 1986.
18. Baird JL, JA Raper: A serine proteinase involved in contact mediated repulsion of retinal growth cones by DRG neurites. J Neurosci 15:6605-6618, 1995.
19. Hawkins RL, NW Seeds: Protease inhibitors influence the direction of neurite outgrowth. Brain Res Dev Brain Res 45:203-209, 1989.
20. Snider RM, E Richelson: Thrombin stimulation of guanosine 3′,5′-monophosphate formation in murine neuroblastoma cells (clone NIE-115). Science 221:566-568, 1983.
21. Snider RM, M McKinney, JW Fenton II, E Richelson: Activation of cyclic nucleotide formation in murine neuroblastoma NIE-115 cells by modified human thrombins. J Biol Chem 259:9078-9081, 1984.
22. Perraud F, F Besnard, M Sensenbrenner, G Labourdette: Thrombin is a potent mitogen for rat astroblasts but not for oligodendroblasts and neuroblasts in primary culture. Int J Dev Neurosci 5:181-188, 1987.
23. Neveu I, F Jehan, M Jandrot-Perrus, D Wion, P Brachet: Enhancement of the synthesis and secretion of nerve growth factor in primary cultures of glial cells by proteases: A possible involvement of thrombin. J Neurochem 60:858-867, 1993.
24. Vaughan PJ, CJ Pike, CW Cotman, DD Cunningham: Thromhin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci 15:5389-5401, 1995.
25. 2+ homeostasis and sensitivity to glucose deprivation-induced injury. J Neurosci 15:5840-5850, 1995.
26. Vu T-KH, DT Hung, VI Wheaton, SR Coughlin: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068, 1991.
27. 2+ mobilization. FEBS Lett 288:123-128, 1991.
28. Zhong C, DJ Hayzer, MA Corson, MS Runge: Molecular cloning of the rat vascular smooth muscle thrombin receptor. Evidence for in vitro regulation by basic fibroblast growth factor. J Biol Chem 267:16975-16979, 1992.
29. Vu T-KH, VI Wheaton, DT Hung, I Charo, SR Coughlin: Domains specifying thrombin-receptor interaction. Nature 353:674-677, 1991.
30. Gerszten RE, J Chen, M Ishii, K Ishii, L Wang, T Nanevicz, CW Turck, T-KH Vu, SR Coughlin: Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature 368:648-651, 1994.
31. Suidan HS, SR Stone, BA Hemmings, D Monard: Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron 8:363-375, 1992.
32. Jalink K, WH Moolenaar: Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messengers. J Cell Biol 118:411-419, 1992.
33. Suidan HS, D Monard: How does thrombin cause neurite retraction? In: Fedoroff S, BHJ Juurlink, R Doucettes (Eds): Biology and Pathology of Astrocyte-Neuron Interaction. Plenum Press, New York, 1993, pp 181-191.
34. Beecher KL, TT Andersen, JW Fenton II, BW Festoff: Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture. J Neurosci Res 37:108-115, 1994.
35. Herrick-Davis K, G Camussi, F Bussolino, C Baglioni: Modulation of neurite outgrowth in neuroblastoma cells by protein kinase C and platelet-activating factor. J Biol Chem 266:18620-18625, 1991.
36. Jalink K, EJ van Corven, T Hengeveld, N Morii, S Narumiya, WH Moolenaar: Inhibition of lysophosphatidate- and thrombin-induced neurite retraction and neuronal cell rounding by ADP ribosylation of the small GTP-binding protein Rho. J Cell Biol 126:801-810, 1994.
37. Suidan HS, J Bouvier, E Schaerer, SR Stone, D Monard, J Tschopp: Granzyme A released upon stimulation of cytotoxic T lymphocytes activates the thrombin receptor on neuronal cells and astrocytes. Proc Natl Acad Sci USA 91:8112-8116, 1994.
38. Kinlough-Rathbone RL, ML Rand, MA Packham: Rabbit and rat platelets do not respond to thrombin receptor peptides that activate human platelets. Blood 82:103-106, 1993.
39. Cook NS, HG Zerwes, C Tapparelli, M Powling, J Singh, R Metternich, A Hagenbach: Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: Activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Thromb Haemostas 70:531-539, 1993.
40. Tapparelli C, R Metternich, C Ehrhardt, M Zurini, G Claeson, MF Scully, SR Stone: In vitro and in vivo characterization of a neutral boron-containing thrombin inhibitor. J Biol Chem 268:4734-4741, 1993.
41. Connolly TM, C Coudra, DM Feng, JJ Cook, MT Stranieri, CF Reilly, RF Nutt, RJ Gould: Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides. Thromb Haemostas 72:627-633, 1994.
42. McKinney M, RM Snider, E Richelson: Thrombin binding to human brain and spinal cord. Mayo Clin Proc 58:829-831, 1983.
43. Means ED, DK Anderson: Thrombin interactions with central nervous system tissue and implications of these interactions. Ann NY Acad Sci 485:314-322, 1986.
44. Soifer SJ, KG Peters, J O'Keefe, SR Coughlin: Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Am J Pathol 144:60-69, 1994.
45. Niclou S, HS Suidan, M Brown-Luedi, D Monard: Expression of the thrombin receptor mRNA in rat brain. Cell Mol Biol 40:421-428, 1994.
46. Weinstein JR, SJ Gold, DD Cunningham, CM Gall: Cellular localization of thrombin receptor mRNA in rat brain: Expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci 15:2906-2919, 1995.
47. Dihanich M, M Kaser, E Reinhard, D Cunningham, D Monard: Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6:575-581, 1991.
48. Deschepper CF, V Bigornia, ME Berens, MC Lapointe: Production of thrombin and antithrombin III by brain and astroglial cell cultures. Mol Brain Res 11:355-358, 1991.
49. Jamison CS, SJF Degen: Prenatal and postnatal expression of mRNA coding for rat prothrombin. Biochim Biophys Acta 1088: 208-216, 1991.
50. Grand RJ, PW Grabham, MJ Gallimore, PH Gallimore: Modulation of morphological differentiation of human neuroepithelial cells by serine proteases: Independence from blood coagulation. EMBO J 8:2209-2215, 1989.
51. Grabham PW, RJ Grand, PH Gallimore: Purification of a serum factor which reverses dibutyryl cAMP induced differentiation. Cell Signal 1:269-281, 1989.
52. Nelken NA, SJ Soifer, KJ O, T-KH Vu, IF Charo, SR Coughlin: Thrombin receptor expression in normal and atherosclerotic human arteries. J Clin Invest 90:1614-1621, 1992.
53. Liu Y, RD Fields, BW Festoff, PG Nelson: Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc Natl Acad Sci USA 91:10300-10304, 1994.
54. Ogino Y, T Costa: Thrombin is the major serum factor stimulating phosphoinositide turnover, but not DNA synthesis in human neuroblastoma SH-EP cells. Eur J Pharmacol 225:299-303, 1992.
55. Snider RM: Thrombin effects on cultured nerve cells: Clinical implications and evidence for a novel mechanism of neuronal activation. Ann NY Acad Sci 485:310-313, 1986.
56. Cunningham DD, L Pulliam, PJ Vaughan: Protease nexin-1 and thrombin: Injury-related processes in the brain. Thromb Haemostas 70:168-171, 1993.
57. Nishino A, M Suzuki, H Ohtani, O Motohashi, K Umezawa, H Nagura, T Yoshimoto: Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 10:167-179, 1993.
58. Nishino A, M Suzuki, T Yoshimoto, H Otani, H Nagura: A novel aspect of thrombin in the tissue reaction following central nervous system injury. Acta Neurochirur Suppl 60:86-88, 1994.
59. Wagner SL, JW Geddes, CW Cotman, AL Lau, D Gurwitz, PJ Isackson, DD Cunningham: Protease nexin-1, an antithrombin with neunte outgrowth activity, is reduced in Alzheimer disease. Proc Natl Acad Sci USA 86:8284-8288, 1989.
60. Akiyama H, K Ikeda, H Kondo, PL McGeer: Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci Lett 146:152-154, 1992.
61. Chong YH, JM Jung, W Choi, CW Park, KS Choi, YH Suh: Bacterial expression, purification of full length and carboxyl terminal fragment of Alzheimer amyloid precursor protein and their proteolytic processing by thrombin. Life Sci 54:1259-1268, 1994.
62. Chomczynski P, N Sacchi: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
63. 3H]-adenine. Anal Biochem 205:159-165, 1992.